![Marc Schegerin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Schegerin
Directeur Financier/CFO chez
MORC HOLD
Profil
Marc Schegerin is currently Independent Director at SQZ Biotechnologies Co. since 2020.
Since 2020, also Chief Financial & Operating Officer at Morphic Therapeutic, Inc. and Chief Operating & Financial Officer at Morphic Holding, Inc. Formerly Program Director at Biogen, Inc. from 2009 to 2013.
Senior Director at SAGE Therapeutics, Inc. from 2013 to 2014.
Director at Citigroup, Inc. from 2016 to 2018.
Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc. from 2019 to 2020.
Education includes undergraduate degrees from Tulane University (Louisiana) and Harvard University, a doctorate from Dartmouth Medical School, and an MBA from Tuck School of Business at Dartmouth.
Postes actifs de Marc Schegerin
| Sociétés | Poste | Début |
|---|---|---|
| MORC HOLD | Directeur Financier/CFO | 06/04/2020 |
| SQZ BIOTECHNOLOGIES COMPANY | Directeur/Membre du Conseil | 23/10/2020 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Directeur Financier/CFO | 01/04/2020 |
Anciens postes connus de Marc Schegerin
| Sociétés | Poste | Fin |
|---|---|---|
| ARQULE, INC. | Directeur Financier/CFO | 01/01/2020 |
| CITIGROUP INC. | Directeur/Membre du Conseil | 01/04/2018 |
| SAGE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2013 |
Formation de Marc Schegerin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Choisissez Zonebourse 
